These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Vaccines against bluetongue in Europe. Savini G; MacLachlan NJ; Sanchez-Vizcaino JM; Zientara S Comp Immunol Microbiol Infect Dis; 2008 Mar; 31(2-3):101-20. PubMed ID: 17765305 [TBL] [Abstract][Full Text] [Related]
3. Bluetongue viruses based on modified-live vaccine serotype 6 with exchanged outer shell proteins confer full protection in sheep against virulent BTV8. van Gennip RG; van de Water SG; Maris-Veldhuis M; van Rijn PA PLoS One; 2012; 7(9):e44619. PubMed ID: 23049753 [TBL] [Abstract][Full Text] [Related]
4. Protective duration of immunity of an inactivated bluetongue (BTV) serotype 2 vaccine against a virulent BTV serotype 2 challenge in sheep. Hamers C; Rehbein S; Hudelet P; Blanchet M; Lapostolle B; Cariou C; Duboeuf M; Goutebroze S Vaccine; 2009 May; 27(21):2789-93. PubMed ID: 19366576 [TBL] [Abstract][Full Text] [Related]
5. Determination of the minimum protective dose for bluetongue virus serotype 2 and 8 vaccines in sheep. Modumo J; Venter EH J S Afr Vet Assoc; 2012 Aug; 83(1):17. PubMed ID: 23327131 [TBL] [Abstract][Full Text] [Related]
6. Efficacy of vaccination for bluetongue virus serotype 8 performed shortly before challenge and implications for animal trade. Spedicato M; Lorusso A; Salini R; Gennaro AD; Leone A; Teodori L; Casaccia C; Portanti O; Calistri P; Giovannini A; Savini G Prev Vet Med; 2017 Jan; 136():49-55. PubMed ID: 28010907 [TBL] [Abstract][Full Text] [Related]
7. Differentiation between field and vaccine strain of bluetongue virus serotype 16. Monaco F; Cammà C; Serini S; Savini G Vet Microbiol; 2006 Aug; 116(1-3):45-52. PubMed ID: 16713688 [TBL] [Abstract][Full Text] [Related]
8. Efficacy of three inactivated vaccines against bluetongue virus serotype 8 in sheep. Eschbaumer M; Hoffmann B; König P; Teifke JP; Gethmann JM; Conraths FJ; Probst C; Mettenleiter TC; Beer M Vaccine; 2009 Jun; 27(31):4169-75. PubMed ID: 19406189 [TBL] [Abstract][Full Text] [Related]
9. Risk factors associated with the occurrence of undesired effects in sheep and goats after field vaccination with modified-live vaccine against bluetongue virus serotypes 2, 4 and 16. Savini G; Cannas A; Casaccia C; Di Gialleonardo L; Leone A; Patta C; Nicolussi P Vet Microbiol; 2010 Nov; 146(1-2):44-50. PubMed ID: 20537822 [TBL] [Abstract][Full Text] [Related]
10. Protective efficacy of Bluetongue virus-like and subvirus-like particles in sheep: presence of the serotype-specific VP2, independent of its geographic lineage, is essential for protection. Stewart M; Dovas CI; Chatzinasiou E; Athmaram TN; Papanastassopoulou M; Papadopoulos O; Roy P Vaccine; 2012 Mar; 30(12):2131-9. PubMed ID: 22285887 [TBL] [Abstract][Full Text] [Related]
12. Laboratory tests for evaluating the level of attenuation of bluetongue virus. Franchi P; Mercante MT; Ronchi GF; Armillotta G; Ulisse S; Molini U; Di Ventura M; Lelli R; Savini G; Pini A J Virol Methods; 2008 Nov; 153(2):263-5. PubMed ID: 18706450 [TBL] [Abstract][Full Text] [Related]
13. Clinical and serological response of sheep to serial challenge with different bluetongue virus types. Jeggo MH; Gumm ID; Taylor WP Res Vet Sci; 1983 Mar; 34(2):205-11. PubMed ID: 6304836 [TBL] [Abstract][Full Text] [Related]
14. Neutralising antibody responses in cattle and sheep following booster vaccination with two commercial inactivated bluetongue virus serotype 8 vaccines. Bartram DJ; Heasman L; Batten CA; Oura CA; Plana-Durán J; Yuen HM; Wylie AD Vet J; 2011 May; 188(2):193-6. PubMed ID: 20466568 [TBL] [Abstract][Full Text] [Related]
15. Application of bluetongue Disabled Infectious Single Animal (DISA) vaccine for different serotypes by VP2 exchange or incorporation of chimeric VP2. Feenstra F; Pap JS; van Rijn PA Vaccine; 2015 Feb; 33(6):812-8. PubMed ID: 25510389 [TBL] [Abstract][Full Text] [Related]
16. An inactivated vaccine for the control of bluetongue virus serotype 16 infection in sheep in Italy. Savini G; Ronchi GF; Leone A; Ciarelli A; Migliaccio P; Franchi P; Mercante MT; Pini A Vet Microbiol; 2007 Sep; 124(1-2):140-6. PubMed ID: 17499459 [TBL] [Abstract][Full Text] [Related]
17. Comparison of genome segments 2, 7 and 10 of bluetongue viruses serotype 2 for differentiation between field isolates and the vaccine strain. Bréard E; Sailleau C; Coupier H; Mure-Ravaud K; Hammoumi S; Gicquel B; Hamblin C; Dubourget P; Zientara S Vet Res; 2003; 34(6):777-89. PubMed ID: 14746772 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of cross-protection of bluetongue virus serotype 4 with other serotypes in sheep. Zulu GB; Venter EH J S Afr Vet Assoc; 2014 Oct; 85(1):1041. PubMed ID: 25686101 [TBL] [Abstract][Full Text] [Related]
19. Immunologic response of sheep to inactivated and virulent bluetongue virus. Stott JL; Barber TL; Osburn BI Am J Vet Res; 1985 May; 46(5):1043-9. PubMed ID: 2988376 [TBL] [Abstract][Full Text] [Related]
20. Colostral antibody protection and interference with immunity in lambs born from sheep vaccinated with an inactivated Bluetongue serotype 8 vaccine. Oura CA; Wood JL; Floyd T; Sanders AJ; Bin-Tarif A; Henstock M; Edwards L; Simmons H; Batten CA Vaccine; 2010 Mar; 28(15):2749-53. PubMed ID: 20123052 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]